Medical decision making in antipsychotic drug choice for schizophrenia
Medical decision making in antipsychotic drug choice for schizophrenia
复制标题
DOI：
10.1176/appi.ajp.161.7.1301
复制
发表时间：
2004-07-01
影响因子：
17.7
通讯作者：
Kissling, W
中科院分区：
文献类型：
--
作者：
Hamann, J;Langer, B;Kissling, W
目的：探讨患者变量和医生变量对精神分裂症患者抗精神病药物选择的影响。方法：对200例精神分裂症患者的100名精神科医生进行药物选择访谈。使用多元Logistic回归分析数据。结果：老年医生开第一代抗精神病药物的可能性高达5倍。患者变量对治疗决策的影响不显著。结论：临床决策和质量管理方面迫切需要更多的研究。
Objective: The influence of patient and physician variables on antipsychotic drug choice for patients with schizophrenia was assessed.Method: Interviews with 100 psychiatrists on drug choice for 200 patients suffering from schizophrenia were conducted. Data were analyzed by using multiple logistic regression.Results: Older physicians were up to five times more likely to prescribe first-generation antipsychotics. Patient variables did not influence treatment decisions significantly.Conclusions: There is an urgent need for more research on clinical decision making and quality management.